Lower back pain (LBP) is highly prevalent worldwide, with its incidence significantly influenced by age, profession, and level of activity:
Age: The highest incidence occurs in middle-aged and older adults, particularly between ages 45–64. The global burden of LBP among working-age individuals (15–64 years) reached 452.8 million cases in 2021, with a continued increase projected through 2050. The peak burden for females is observed in the 50–54 age group and for males in the 55–59 age group15.
Profession: Occupations that involve heavy physical labor, repetitive movements, awkward postures, or prolonged sitting (such as healthcare workers, manual laborers, and office workers) are more susceptible to LBP. Occupational ergonomic risks remain a critical factor in the growing burden of LBP globally5.
Level of Activity: Both low and excessively high levels of physical activity are associated with higher LBP risk. Physically demanding jobs and sedentary lifestyles both increase the incidence. A moderate level of regular activity is generally regarded as protective5.
Additionally, females consistently show higher incidence and disability rates from LBP across most age and occupational groups. Population growth and aging are primary drivers of the increasing global burden of LBP15.
Evidence-based recommendations for the treatment of lower back pain based on recent clinical guidelines include:
Acute Low Back Pain: Guidelines recommend first-line use of non-steroidal anti-inflammatory drugs (NSAIDs), therapeutic exercise, staying active, and spinal manipulation. Bed rest should be avoided, and patients should be encouraged to maintain normal activities as much as possible1.
Subacute Low Back Pain: Similar to acute cases, recommended treatments are NSAIDs, therapeutic exercise, maintaining activity, and spinal manipulation1.
Chronic Low Back Pain: Strong evidence supports therapeutic exercise and continued activity. Additional recommendations include NSAIDs (with careful risk assessment), spinal manipulation, and acupuncture. For selected patients, cognitive and behavioral therapies (e.g., acceptance and commitment therapy, cognitive-behavioral therapy) and self-management approaches are also effective. Duloxetine (an SNRI) has moderate evidence of efficacy for selected patients12.
General Considerations:
Opioids should generally be avoided due to insufficient evidence and risk of harm3.
Imaging is not routinely recommended unless red flag symptoms are present.
Multimodal and interdisciplinary approaches are encouraged for chronic cases.
The emphasis is on conservative, non-pharmacological management as first-line treatment12.